-
Something wrong with this record ?
A vision to the future: value-based laboratory medicine
M. Plebani, J. Cadamuro, P. Vermeersch, S. Jovičić, T. Ozben, T. Trenti, B. McMillan, CR. Lowe, J. Lennerz, E. Macintyre, C. Gabelli, S. Sandberg, A. Padoan, JR. Wiencek, G. Banfi, IM. Lubin, M. Orth, A. Carobene, T. Zima, CM. Cobbaert, RHN. van...
Language English Country Germany
Document type Journal Article
- MeSH
- Laboratories, Clinical * economics trends MeSH
- Clinical Laboratory Techniques economics trends MeSH
- Congresses as Topic MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion of test volume and cost, in favor of emphasizing the clinical utility and quality of diagnostic tests in the clinical decision-making. Several key elements characterize value-based laboratory medicine, which can be summarized in some basic concepts, such as organization of in vitro diagnostics (including appropriateness, integrated diagnostics, networking, remote patient monitoring, disruptive innovations), translation of laboratory data into clinical information and measurable outcomes, sustainability, reimbursement, ethics (e.g., patient empowerment and safety, data protection, analysis of big data, scientific publishing). Education and training are also crucial, along with considerations for the future of the profession, which will be largely influenced by advances in automation, information technology, artificial intelligence, and regulations concerning in vitro diagnostics. This collective opinion paper, composed of summaries from presentations given at the two-day European Federation of Laboratory Medicine (EFLM) Strategic Conference "A vision to the future: value-based laboratory medicine" (Padova, Italy; September 23-24, 2024), aims to provide a comprehensive overview of value-based laboratory medicine, projecting the profession into a more clinically effective and sustainable future.
Bianalisi Group Monza Roma Italy
Centre of Primary Care and Health Services Research University of Manchester Manchester UK
Clinical Department of Laboratory Medicine UZ Leuven Leuven Belgium
Department of Clinical Chemistry Erasmus MC University Medical Center Rotterdam The Netherlands
Department of Laboratory Medicine Paracelsus Medical University Salzburg Austria
Department of Laboratory Medicine University of Padova Padova Italy
Department of Medical Biochemistry Faculty of Pharmacy University of Belgrade Belgrade Serbia
Department of Medicine University of Padova Padova Italy
Department of Pathology Microbiology and Immunology Vanderbilt School of Medicine Nashville TN USA
Heidelberg University Heidelberg Germany
IRCCS Galeazzi Sant'Ambrogio Milan Italy
Laboratory Medicine IRCCS San Raffaele Scientific Institute Milan Italy
Laboratory Medicine Unit University Hospital of Padova Padova Italy
Medical Faculty Department of Medical Biochemistry Akdeniz University Antalya Türkiye
Medical Faculty of Mannheim Vinzenz von Paul Kliniken gGmbH Stuttgart Germany
Noklus Haraldsplass Deaconess Hospital Bergen Norway
Onco Hematology Laboratory Necker Hospital and Université Paris Cité Paris France
Research Centre for Brain Aging University Hospital of Padua Padova Italy
Section of Clinical Biochemistry University of Verona Verona Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003390
- 003
- CZ-PrNML
- 005
- 20250206104320.0
- 007
- ta
- 008
- 250121s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/cclm-2024-1022 $2 doi
- 035 __
- $a (PubMed)39259894
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Plebani, Mario $u Department of Laboratory Medicine, University of Padova, Padova, Italy
- 245 12
- $a A vision to the future: value-based laboratory medicine / $c M. Plebani, J. Cadamuro, P. Vermeersch, S. Jovičić, T. Ozben, T. Trenti, B. McMillan, CR. Lowe, J. Lennerz, E. Macintyre, C. Gabelli, S. Sandberg, A. Padoan, JR. Wiencek, G. Banfi, IM. Lubin, M. Orth, A. Carobene, T. Zima, CM. Cobbaert, RHN. van Schaik, G. Lippi
- 520 9_
- $a The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion of test volume and cost, in favor of emphasizing the clinical utility and quality of diagnostic tests in the clinical decision-making. Several key elements characterize value-based laboratory medicine, which can be summarized in some basic concepts, such as organization of in vitro diagnostics (including appropriateness, integrated diagnostics, networking, remote patient monitoring, disruptive innovations), translation of laboratory data into clinical information and measurable outcomes, sustainability, reimbursement, ethics (e.g., patient empowerment and safety, data protection, analysis of big data, scientific publishing). Education and training are also crucial, along with considerations for the future of the profession, which will be largely influenced by advances in automation, information technology, artificial intelligence, and regulations concerning in vitro diagnostics. This collective opinion paper, composed of summaries from presentations given at the two-day European Federation of Laboratory Medicine (EFLM) Strategic Conference "A vision to the future: value-based laboratory medicine" (Padova, Italy; September 23-24, 2024), aims to provide a comprehensive overview of value-based laboratory medicine, projecting the profession into a more clinically effective and sustainable future.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a klinické laboratorní techniky $x ekonomika $x trendy $7 D019411
- 650 12
- $a klinické laboratoře $x ekonomika $x trendy $7 D000090464
- 650 _2
- $a kongresy jako téma $7 D003226
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cadamuro, Janne $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
- 700 1_
- $a Vermeersch, Pieter $u Clinical Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium
- 700 1_
- $a Jovičić, Snežana $u Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Ozben, Tomris $u Medical Faculty, Department of Medical Biochemistry, Akdeniz University, Antalya, Türkiye $u Medical Faculty, Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy
- 700 1_
- $a Trenti, Tommaso $u Bianalisi Group Monza, Roma, Italy
- 700 1_
- $a McMillan, Brian $u Centre of Primary Care and Health Services Research, University of Manchester, Manchester, UK
- 700 1_
- $a Lowe, Christopher R $u Trinity College, University of Cambridge, Cambridge, UK
- 700 1_
- $a Lennerz, Jochen $u BostonGene, Waltham, MA, USA
- 700 1_
- $a Macintyre, Elizabeth $u Onco-Hematology Laboratory, Necker Hospital and Université Paris Cité, Paris, France
- 700 1_
- $a Gabelli, Carlo $u Research Centre for Brain Aging (CRIC), University Hospital of Padua, Padova, Italy
- 700 1_
- $a Sandberg, Sverre $u Noklus, Haraldsplass Deaconess Hospital, Bergen, Norway
- 700 1_
- $a Padoan, Andrea $u Department of Medicine, University of Padova, Padova, Italy $u Laboratory Medicine Unit, University-Hospital of Padova, Padova, Italy
- 700 1_
- $a Wiencek, Joesph R $u Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA
- 700 1_
- $a Banfi, Giuseppe $u IRCCS Galeazzi Sant'Ambrogio, Milan, Italy $u University Vita e Salute San Raffaele, Milan, Italy
- 700 1_
- $a Lubin, Ira M $u Division of Laboratory Systems, Center for Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 700 1_
- $a Orth, Matthias $u Medical Faculty of Mannheim, Vinzenz von Paul Kliniken gGmbH, Stuttgart, Germany $u Heidelberg University, Heidelberg, Germany
- 700 1_
- $a Carobene, Anna $u Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Cobbaert, Christa M $u Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands $u EFLM Committee on European Regulatory Affairs and EFLM Liaison to BioMed Alliance in Europe, Brussels, Belgium
- 700 1_
- $a van Schaik, Ron H N $u Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands
- 700 1_
- $a Lippi, Giuseppe $u Section of Clinical Biochemistry, University of Verona, Verona, Italy $1 https://orcid.org/0000000195239054
- 773 0_
- $w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 62, č. 12 (2024), s. 2373-2387
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39259894 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104316 $b ABA008
- 999 __
- $a ok $b bmc $g 2263270 $s 1239397
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 62 $c 12 $d 2373-2387 $e 20240913 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
- LZP __
- $a Pubmed-20250121
